BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 16080543)

  • 1. Prostate cancer and inositol hexaphosphate: efficacy and mechanisms.
    Singh RP; Agarwal R
    Anticancer Res; 2005; 25(4):2891-903. PubMed ID: 16080543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer chemoprevention by silibinin: bench to bedside.
    Singh RP; Agarwal R
    Mol Carcinog; 2006 Jun; 45(6):436-42. PubMed ID: 16637061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inositol hexaphosphate inhibits growth and induces G1 arrest and apoptotic death of androgen-dependent human prostate carcinoma LNCaP cells.
    Agarwal C; Dhanalakshmi S; Singh RP; Agarwal R
    Neoplasia; 2004; 6(5):646-59. PubMed ID: 15548374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth inhibitory and apoptotic effects of inositol hexaphosphate in transgenic adenocarcinoma of mouse prostate (TRAMP-C1) cells.
    Sharma G; Singh RP; Agarwal R
    Int J Oncol; 2003 Nov; 23(5):1413-8. PubMed ID: 14532984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary feeding of silibinin inhibits prostate tumor growth and progression in transgenic adenocarcinoma of the mouse prostate model.
    Raina K; Blouin MJ; Singh RP; Majeed N; Deep G; Varghese L; Glodé LM; Greenberg NM; Hwang D; Cohen P; Pollak MN; Agarwal R
    Cancer Res; 2007 Nov; 67(22):11083-91. PubMed ID: 18006855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel anticancer function of inositol hexaphosphate: inhibition of human rhabdomyosarcoma in vitro and in vivo.
    Vucenik I; Kalebic T; Tantivejkul K; Shamsuddin AM
    Anticancer Res; 1998; 18(3A):1377-84. PubMed ID: 9673344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IP6-induced growth inhibition and differentiation of HT-29 human colon cancer cells: involvement of intracellular inositol phosphates.
    Yang GY; Shamsuddin AM
    Anticancer Res; 1995; 15(6B):2479-87. PubMed ID: 8669811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IP6 in treatment of liver cancer. II. Intra-tumoral injection of IP6 regresses pre-existing human liver cancer xenotransplanted in nude mice.
    Vucenik I; Zhang ZS; Shamsuddin AM
    Anticancer Res; 1998; 18(6A):4091-6. PubMed ID: 9891450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cancer chemopreventive agent silibinin, targets mitogenic and survival signaling in prostate cancer.
    Singh RP; Agarwal R
    Mutat Res; 2004 Nov; 555(1-2):21-32. PubMed ID: 15476849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of action of novel agents for prostate cancer chemoprevention.
    Singh RP; Agarwal R
    Endocr Relat Cancer; 2006 Sep; 13(3):751-78. PubMed ID: 16954429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silibinin suppresses in vivo growth of human prostate carcinoma PC-3 tumor xenograft.
    Singh RP; Deep G; Blouin MJ; Pollak MN; Agarwal R
    Carcinogenesis; 2007 Dec; 28(12):2567-74. PubMed ID: 17916909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammary tumor inhibition by IP6: a review.
    Shamsuddin AM; Vucenik I
    Anticancer Res; 1999; 19(5A):3671-4. PubMed ID: 10625937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against cancer by dietary IP6 and inositol.
    Vucenik I; Shamsuddin AM
    Nutr Cancer; 2006; 55(2):109-25. PubMed ID: 17044765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo suppression of hormone-refractory prostate cancer growth by inositol hexaphosphate: induction of insulin-like growth factor binding protein-3 and inhibition of vascular endothelial growth factor.
    Singh RP; Sharma G; Mallikarjuna GU; Dhanalakshmi S; Agarwal C; Agarwal R
    Clin Cancer Res; 2004 Jan; 10(1 Pt 1):244-50. PubMed ID: 14734476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impairment of erbB1 receptor and fluid-phase endocytosis and associated mitogenic signaling by inositol hexaphosphate in human prostate carcinoma DU145 cells.
    Zi X; Singh RP; Agarwal R
    Carcinogenesis; 2000 Dec; 21(12):2225-35. PubMed ID: 11133812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An androgen-independent androgen receptor function protects from inositol hexakisphosphate toxicity in the PC3/PC3(AR) prostate cancer cell lines.
    Diallo JS; Péant B; Lessard L; Delvoye N; Le Page C; Mes-Masson AM; Saad F
    Prostate; 2006 Sep; 66(12):1245-56. PubMed ID: 16705740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inositol hexaphosphate inhibits constitutive activation of NF- kappa B in androgen-independent human prostate carcinoma DU145 cells.
    Agarwal C; Dhanalakshmi S; Singh RP; Agarwal R
    Anticancer Res; 2003; 23(5A):3855-61. PubMed ID: 14666688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inositol hexaphosphate inhibits tumor growth, vascularity, and metabolism in TRAMP mice: a multiparametric magnetic resonance study.
    Raina K; Ravichandran K; Rajamanickam S; Huber KM; Serkova NJ; Agarwal R
    Cancer Prev Res (Phila); 2013 Jan; 6(1):40-50. PubMed ID: 23213071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemopreventive efficacy of inositol hexaphosphate against prostate tumor growth and progression in TRAMP mice.
    Raina K; Rajamanickam S; Singh RP; Agarwal R
    Clin Cancer Res; 2008 May; 14(10):3177-84. PubMed ID: 18483386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA).
    Lee SO; Yeon Chun J; Nadiminty N; Trump DL; Ip C; Dong Y; Gao AC
    Prostate; 2006 Jul; 66(10):1070-5. PubMed ID: 16637076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.